One’s a pop star fighting an oppressive conservatorship, the other’s a giant pharmaceuticals company fighting enormous reputational damage. Will the AstraZeneca/Britney Spears stories play out the same?
Is AstraZeneca the Britney Spears of COVID vaccines? AstraZeneca in Australia has the same problem Spears has in the United States — too little voice and too many other people making decisions to determine their future.
Spears only very recently finally spoke out publicly against an oppressive conservatorship that is dictating her personal life and her professional brand.
Meanwhile in Australia, AstraZeneca has effectively been silent in public in the face of concerns over rare side-effects and criticism of the local vaccine rollout.
Want to know more about the comparison?
Already a subscriber? Log in to keep reading.
Or, register your email address for a FREE 21-day trial.